<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p424.xml</sm:loc><ifp:title>Historical Views, Conventional Approaches, and Evolving Management Strategies for Myeloproliferative Neoplasms</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p424.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Historical Views, Conventional Approaches, and Evolving Management Strategies for Myeloproliferative Neoplasms</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p417.xml</sm:loc><ifp:title>Delayed Recovery and Increased Severity of Paclitaxel-Induced Peripheral Neuropathy in Patients With Diabetes</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p417.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Delayed Recovery and Increased Severity of Paclitaxel-Induced Peripheral Neuropathy in Patients With Diabetes</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p409.xml</sm:loc><ifp:title>Impact of NCI-Mandated Scientific Review on Protocol Development and Content</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p409.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Impact of NCI-Mandated Scientific Review on Protocol Development and Content</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p375.xml</sm:loc><ifp:title>Turf War Over Diagnostic Testing</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p375.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Turf War Over Diagnostic Testing</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-pxxxviii.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-pxxxviii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-plvi.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-plvi.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p395.xml</sm:loc><ifp:title>Cervical Cancer, Version 2.2015</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p395.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Cervical Cancer, Version 2.2015</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p387.xml</sm:loc><ifp:title>A Novel Approach Using Sorafenib in Alpha Fetoprotein–Producing Hepatoid Adenocarcinoma of the Lung</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p387.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>A Novel Approach Using Sorafenib in Alpha Fetoprotein–Producing Hepatoid Adenocarcinoma of the Lung</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p376.xml</sm:loc><ifp:title>Breast Cancer Risk Reduction Therapy: The Low-Hanging Fruit</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p376.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Breast Cancer Risk Reduction Therapy: The Low-Hanging Fruit</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p380.xml</sm:loc><ifp:title>NCCN: Touched by Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p380.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN: Touched by Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p448.xml</sm:loc><ifp:title>Breast Cancer Version 2.2015</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p448.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Breast Cancer Version 2.2015</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p435.xml</sm:loc><ifp:title>Development of a Hematology/Oncology ICD-10 Documentation Job Aid</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p435.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Development of a Hematology/Oncology ICD-10 Documentation Job Aid</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-pe19.xml</sm:loc><ifp:title>Molecular Biomarkers in Gastric Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-pe19.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Molecular Biomarkers in Gastric Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p487.xml</sm:loc><ifp:title>Surgical Management of De Novo Stage IV Breast Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p487.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Surgical Management of De Novo Stage IV Breast Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p480.xml</sm:loc><ifp:title>Routine Use of Zoledronic Acid in Early-Stage Breast Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p480.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Routine Use of Zoledronic Acid in Early-Stage Breast Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p495.xml</sm:loc><ifp:title>Delivering on the Promise of Patient-Centered Care</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/13/4/article-p495.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Delivering on the Promise of Patient-Centered Care</ifp:title></sm:url></urlset>
